Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria
Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the cure rate from ventilator-associated pneumonia
(VAP) caused by Gram negative bacteria when administering add on nebulized amikacin to
intravenous antibiotics compared to intravenous antibiotics alone.